Vitamin C and Cancer: What the Evidence Does and Does Not Show

Updated 23 October 2026 · Cancer Point

Vitamin C is an essential nutrient. That fact does not establish it as a cancer cure. Claims about food, ordinary supplements and high-dose intravenous vitamin C should be considered separately because they describe different uses.

Food and an infusion are not the same intervention

Vitamin C supports normal body functions, including collagen formation. Intravenous, or IV, administration can produce much higher blood levels than taking it by mouth. A laboratory result involving high concentrations cannot simply be applied to eating fruit or buying an oral supplement.

What the clinical evidence can tell us

NCI's evidence summary describes mixed findings from studies of IV vitamin C, including small studies alongside standard cancer treatment. Some report improvements in quality of life or side effects, but these findings do not establish a general cancer cure. The US FDA has not approved IV vitamin C as a cancer treatment.

“Studied in people” is the beginning of an evidence discussion, not the end. A study may be designed to assess safety, feasibility or a symptom rather than whether patients live longer. Results from one cancer and treatment combination should not be generalized to every cancer.

Make a claim-checking note

Before an appointment, record the exact product or service, the outcome promised and the evidence supplied by the provider. Add these questions:

• Does the research involve my cancer and treatment situation?
• Was vitamin C used in addition to standard treatment?
• Was there a comparison group, and how large was the study?
• What was measured: symptoms, tumour response or survival?
• What remains uncertain, and what would change the recommendation?

Ask for a full study reference. A testimonial, an impressive-looking graph without its source or a claim that research is being suppressed is not enough to make a medical decision. Our guide to complementary and alternative care explains the difference between symptom support and replacing treatment.

High doses can carry risks

NCI identifies particular concerns with IV vitamin C in people with kidney disease, G6PD deficiency or iron overload disorders. Possible interactions with cancer medicines also require assessment. Do not arrange an infusion or high-dose supplement without discussing the full proposal with the oncology team.

Bring ingredient information and the provider's proposed schedule to that discussion. Ask who would check suitability, monitor problems and communicate with the treating oncologist. A reassuring label such as “natural” does not answer these questions.

Separate nutritional care from a cancer-treatment claim

If eating has become difficult or a deficiency is suspected, ask for an assessment of nutrition needs. That is a different conversation from paying for a package promoted to destroy tumours. This page gives no dosing instructions because nutritional needs, medical conditions and treatment plans differ.

Before paying, request the total cost and clarify whether the service is part of a registered clinical trial or a commercial offer. Ask the oncology team about any suggested treatment delay. Do not postpone established care while trying an unproven cure.

It is reasonable to want every possible option considered. A useful consultation should explain the available evidence and uncertainty without pressuring you to buy immediately. Keep the written advice with your treatment records so everyone involved is working from the same information.

Editorial update: The earlier article overstated vitamin C as an anticancer treatment. Those claims have been removed; this page distinguishes nutritional use, research and proven cancer care.

This guide provides general education, not a diagnosis or a personal treatment plan. Discuss medical decisions with a qualified healthcare professional. It has not received an independent clinical review. Read our editorial policy and medical disclaimer.